Subscribe
Close Sidebar
Politics
States
Economy
Society
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Legal
Movies
Sports
Subscribe
Sign In
Our Views
Politics
States
Economy
Society
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Legal
Movies
Sports
Magazine
Store
Johnson %26 Johnson
Johnson & Johnson Sues Doctors Over Studies Linking Talc Products To Cancer
Abhay Rathore
5mo
Business
Johnson & Johnson Proposes $8.9 Billion To Settle Lawsuits Claiming Their Talcum Powder Caused Cancer
Swarajya Staff
8mo
Business
Johnson & Johnson Announces Separation Of Businesses: Details You Need To Know
Bhaswati Guha Majumder
2yr
News Brief
AHPI Close To Striking A Deal For Import Of J&J's Single-Dose COVID-19 Vaccine Into India Early Next Month
Swarajya Staff
2yr
Insta
India In Discussions With Pfizer, J&J Over Possible Local Manufacturing Of Their Covid Vaccines
Swarajya Staff
3yr
Insta
Prefer Dealing With Centre Directly Instead Of States, Private Players For Covid-19 Jabs: Pfizer, Moderna
Swarajya Staff
3yr
Insta
S Jaishankar To Visit US Next Week To Seal Deals On Covid-19 Vaccine Supplies
Swarajya Staff
3yr
Insta
J&J Plans To Conduct Bridging Trials Of Its Covid Vaccine In India, Awaits DCGI Nod: Report
Swarajya Staff
3yr
Insta
J&J's Single-Dose Covid-19 Vaccine Likely To Be Imported To India By June-July: DBT Secretary Renu Swarup
Swarajya Staff
3yr
Insta
J&J Seeks Indian Drug Regulator's Nod For Phase 3 Trials Of Its Single-Dose COVID-19 Vaccine, Import License: Report
Swarajya Staff
3yr
Insta
US: Johnson & Johnson Halts Shipment of 15 Million COVID Vaccine As Factory Workers Accidentally Conflated Ingredients Of 2 Different Vaccines
Swarajya Staff
3yr
Insta
Johnson & Johnson's Single-Dose COVID-19 Vaccine Approved For Use In European Union
Swarajya Staff
3yr
Insta
India To Make J&J's Single-Dose COVID-19 Vaccine Under Quad Initiative To Help Countries In Indo-Pacific Region: Report
Swarajya Staff
3yr
Insta
US FDA Clears Johnson & Johnson's Single-Dose COVID Vaccine; J&J To Produce A Billion Doses By End Of Year
Swarajya Staff
3yr
Insta
Novavax, J&J Covid-19 Vaccines Show Encouraging Results In Phase 3 Trials
Swarajya Staff
3yr
Insta
Johnson and Johnson's Single-Dose COVID-19 Vaccine Candidate Elicits Strong Immune Response In Phase 1 And 2 Trials
Swarajya Staff
3yr
Insta
Johnson & Johnson Temporarily Pauses Covid-19 Vaccine Trials Due To 'Unexplained' Illness In Study Participant
Swarajya Staff
3yr
Insta
Coronavirus: Johnson & Johnson to Begin Human Trial Of Covid-19 Vaccine In July
IANS
3yr
Insta
After HUL, Tax Department Opens Investigations Against Samsung, J&J For Profiteering From GST Rate Cuts
Swarajya Staff
5yr
Insta
Double Trouble For Johnson & Johnson: After Asbestos Panic, Now It’s Faulty Hip Transplants
Swarajya Staff
5yr
Insta
Load More
Get Swarajya in your inbox.
Subscribe